Cidara Therapeutics (CDTX) said Thursday it has promoted Nicole Davarpanah to chief medical officer.
Davarpanah was most recently a clinical and translational lead at Genentech/Roche, Cidara said.
The company said it also promoted Corrina Pavetto to the role of senior vice president for clinical development.
Shares of Cidara gained more than 5% in recent trading activity.
Price: 22.11, Change: +1.23, Percent Change: +5.87
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.